Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30655904 | 1.00 | F2 (0.30) | F2PRSS1PRSS2PRSS3 | |
| SCHEMBL3958177 | 0.79 | CA1 (0.32) | — | |
| SCHEMBL28408539 | 0.78 | — | — | |
| SCHEMBL3435198 | 0.78 | — | — | |
| SCHEMBL28408544 | 0.75 | F2 (0.31) | F2PRSS1PRSS2PRSS3 | |
| SCHEMBL22325671 | 0.74 | — | — | |
| SCHEMBL28890290 | 0.74 | — | — | |
| SCHEMBL2904316 | 0.74 | CA1 (0.38) | F2PRSS1PRSS2PRSS3 | |
| SCHEMBL28639467 | 0.74 | — | — | |
| SCHEMBL276704 | 0.73 | CA1 (0.35) | F2PRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3428175-B1 | METHOD FOR PRODUCING OLIGOSACCHARIDES AND POLYSACCHARIDES HAVING NON-PROTECTED SULFATE GROUPS | GLYTECH INC (JP) | 2024-09-25 | — | — | EP | claimed |
| US-10797348-B2 | Electrolyte and lithium-ion battery | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2020-10-06 | — | — | US | claimed |
| CN-108258297-B | Electrolyte and lithium ion battery | 宁德时代新能源科技股份有限公司 | 2020-07-17 | — | — | CN | claimed |
| CN-110878110-A | Preparation method of enol-type glycoside | 复旦大学 | 2020-03-13 | — | — | CN | claimed |
| CN-106715448-B | Process for preparing tris (trialkylsilyl) phosphine | SK化学公司 | 2020-03-03 | — | — | CN | claimed |
| EP-3222623-B1 | METHOD FOR PREPARING TRIS(TRIALKYLSILYL)PHOSPHINE | SK CHEMICALS CO LTD (KR) | 2019-08-28 | — | — | EP | claimed |
| US-10040809-B2 | Method for preparing tris(trialkylsilyl)phosphine | SK CHEMICALS CO., LTD. (KR) | 2018-08-07 | — | — | US | claimed |
| US-20180191032-A1 | ELECTROLYTE AND LITHIUM-ION BATTERY | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2018-07-05 | — | — | US | claimed |
| EP-3222623-A1 | METHOD FOR PREPARING TRIS(TRIALKYLSILYL)PHOSPHINE | SK Chemicals Co., Ltd. (KR) | 2017-09-27 | — | — | EP | claimed |
| US-20170226138-A1 | METHOD FOR PREPARING TRIS(TRIALKYLSILYL)PHOSPHINE | SK CHEMICALS CO., LTD. (KR) | 2017-08-10 | — | — | US | claimed |
| EP-4741410-A1 | SOLUBILIZATION GROUP FOR POORLY WATER-SOLUBLE PROTEINS | Glytech, Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-20240391951-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH INC (JP) | 2024-11-28 | — | — | US | disclosed |
| US-12103947-B2 | Methods for producing peptide thioester and peptide | GLYTECH, INC. (JP) | 2024-10-01 | — | — | US | disclosed |
| EP-3428175-B1 | METHOD FOR PRODUCING OLIGOSACCHARIDES AND POLYSACCHARIDES HAVING NON-PROTECTED SULFATE GROUPS | GLYTECH INC (JP) | 2024-09-25 | — | — | EP | disclosed |
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH, INC. (JP) | 2023-05-11 | — | — | US | disclosed |
| CN-102378775-A | Multibranched polyoxyalkylene compound and process for producing the same | NOF CORP | 2012-03-14 | — | — | CN | disclosed |
| EP-2415800-A1 | HYPERBRANCHED POLYOXYALKYLENE COMPOUND AND METHOD FOR PRODUCING SAME | NOF Corporation (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20100261863-A1 | MULTIBRANCHED POLYOXYALKYLENE COMPOUND AND PRODUCING METHOD THEREOF | NOF CORPORATION (JP) | 2010-10-14 | — | — | US | disclosed |
| US-20070219161-A1 | Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2007-09-20 | — | — | US | disclosed |
| WO-2007027752-A1 | CATALYTIC REACTIONS INVOLVING ALKENES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219161-A1 | Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same | OSTC, B3GAT3, CSGALNACT1 | F2 4260/4885PRSS1 3000/4885PRSS2 3054/4885 |
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | QPCT, PTMS, QPCTL | F2 1038/4885PRSS1 1451/4885PRSS2 1164/4885 |
| US-20170226138-A1 | METHOD FOR PREPARING TRIS(TRIALKYLSILYL)PHOSPHINE | INPPL1, TYMP, PHOSPHO1 | F2 1607/4885PRSS1 1244/4885PRSS2 600/4885 |
| US-10040809-B2 | Method for preparing tris(trialkylsilyl)phosphine | INPPL1, TYMP, PHOSPHO1 | F2 1607/4885PRSS1 1244/4885PRSS2 600/4885 |
| US-20100261863-A1 | MULTIBRANCHED POLYOXYALKYLENE COMPOUND AND PRODUCING METHOD THEREOF | OPRM1, AOC2, OPRK1 | F2 2847/4885PRSS1 4213/4885PRSS2 4417/4885 |
| US-12103947-B2 | Methods for producing peptide thioester and peptide | QPCT, QPCTL, PTMS | F2 970/4885PRSS1 1474/4885PRSS2 1139/4885 |
| US-20240391951-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | QPCT, PTMS, QPCTL | F2 1038/4885PRSS1 1451/4885PRSS2 1164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.